Leukemia research on Television
The latest episode of a regional news outlet on German television network SAT.1 featured Prof.Klusmann and Prof.Heckl. The interview gives insights on possible applications of micro RNAs in cancer therapies.
The latest episode of a regional news outlet on German television network SAT.1 featured Prof.Klusmann and Prof.Heckl. The interview gives insights on possible applications of micro RNAs in cancer therapies.
Luca was awarded with the abstract award and presents his work at this years annual meeting of the American Society of Hematology in San Diego.
Publication alert: The identification of long non-coding RNA locus MYNRL15 shows novel therapeutic potential in AMLs with various genetic backgrounds.
Prof. Dirk Heckl takes on a new position and joins the rest of the leukemia research team in Frankfurt.
In this commentary Dr. Uckelmann and Prof. Klusmann point out recent findings that highlight the therapeutic potential of cotargeting IRAK1 and IRAK4.
The lab members made their way to the dkfz in Heidelberg to take part in the 11th International Symposium on Stem Cell and Cancer to present their latest work.
Prof. Klusmann was awarded with a membership of the Leopoldina, Germany's National Academy of Sciences.
In our commentary we highlight a special case of refractory AML, which went into complete remission after Influenza A infection.
Today the work of our PostDoc Dr. Hasan Issa and colleagues was publishe in Leukemia. It presents the anti-leukemic effects of microRNA-193b-3p and its clincial potential.
Last week, the members of the leukemia research group made their way to Wilsede for the annual Kind-Philip-Meeting. A four day meeting packed with great invited lectures and insightfull presentations.